UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recruitment of the Earliest Component of the Bacterial Flagellum to the Old Cell Division Pole by a Membrane-Associated Signal Recognition Particle Family GTP-Binding Protein

Journal of molecular biology, 2009-08, Vol.391 (4), p.679-690

2009

Volltextzugriff (PDF)

Improved uptake and survival with systemic treatments for metastatic non-small cell lung cancer: younger versus older adults

BMC cancer, 2023-04, Vol.23 (1), p.360-360, Article 360

2023

Volltextzugriff (PDF)

Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy

Current oncology (Toronto), 2023-05, Vol.30 (6), p.5299-5308

2023

Volltextzugriff (PDF)

Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing

Current oncology (Toronto), 2022-11, Vol.29 (11), p.8686-8692

2022

Volltextzugriff (PDF)

Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach

PloS one, 2015-09, Vol.10 (9), p.e0139074-e0139074

2015

Volltextzugriff (PDF)

Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world

Cancer medicine (Malden, MA), 2022-01, Vol.11 (1), p.86-93

2022

Volltextzugriff (PDF)

Cell Death and Mechanoprotection by Filamin A in Connective Tissues after Challenge by Applied Tensile Forces

The Journal of biological chemistry, 2002-06, Vol.277 (24), p.21998-22009

2002

Volltextzugriff (PDF)

Uptake of second-line anticancer therapy after first-line pembrolizumab in patients with stage IV non–small cell lung cancer with PD-L1 > 50%: Comparison between clinical trials and the real world

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.126-126

2022

Volltextzugriff (PDF)

Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

Clinical cancer research, 2021-01, Vol.27 (1), p.202-212

2021

Volltextzugriff (PDF)

Overall survival benefits of advances in NSCLC systemic treatments: Younger versus older adults

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.93-93

2021

Volltextzugriff (PDF)

Molecular testing in non-small cell lung cancer: a snapshot of The Royal Free London NHS Foundation Trust experience

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S38

2021

Volltextzugriff (PDF)

The efficacy of crizotinib in patients with -positive nonsmall cell lung cancer

Therapeutic advances in respiratory disease, 2015-06, Vol.9

2015

Volltextzugriff (PDF)

Intratumoral heterogeneity in programmed death‐ligand 1 immunoreactivity is associated with variation in non‐small cell lung carcinoma histotype

Histopathology, 2020-02, Vol.76 (3), p.394-403

2020

Volltextzugriff (PDF)

Confirmation of germline variants identified by tumor testing: A population-based study

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e13021-e13021

2019

Volltextzugriff (PDF)

Lung Cancer in Canada

Journal of thoracic oncology, 2019-07, Vol.14 (7), p.1128-1133

2019

Volltextzugriff (PDF)

Olaratumab: a platelet-derived growth factor receptor-[alpha]-blocking antibody for the treatment of soft tissue sarcoma

Clinical pharmacology: advances and applications, 2017-01, Vol.9, p.159

2017

Volltextzugriff (PDF)

An audit of the management of Staphylococcus aureus bloodstream infections over two years in a District General Hospital in the United Kingdom

The Journal of infection, 2011-12, Vol.63 (6), p.e78-e78

2011

Volltextzugriff (PDF)

An audit of the management of Staphylococcus aureus bloodstream infections over two years in a District General Hospital in the United Kingdom: Category: Clinical lesson

The Journal of infection, 2011-12, Vol.63 (6), p.e78-e78

2011

Volltextzugriff (PDF)

Olaratumab for the treatment of soft-tissue sarcoma

Future oncology (London, England), 2017-10, Vol.13 (24), p.2151-2157

2017

Volltextzugriff (PDF)

Optimising Cancer Vaccine Design in Sarcoma

Cancers, 2018-12, Vol.11 (1), p.1

2018

Volltextzugriff (PDF)

Quantification of circulating free and circulating tumor DNA in pretreated EGFR mutant NSCLC to inform patient outcomes

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9080-9080

2019

Volltextzugriff (PDF)

Understanding lung cancer molecular subtypes

Clinical practice (London, England), 2014-07, Vol.11 (4), p.441-453

2014

Volltextzugriff (PDF)

The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer

Therapeutic Advances in Respiratory Disease, 2015-06, Vol.9 (3), p.97-104

2015

Volltextzugriff (PDF)

The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space

The Journal of molecular diagnostics : JMD, 2022-06, Vol.24 (6), p.609-618

2022

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(36)
Buchkapitel
(4)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recruitment of the Earliest Component of the Bacterial Flagellum to the Old Cell Division Pole by a Membrane-Associated Signal Recognition Particle Family GTP-Binding Protein

Improved uptake and survival with systemic treatments for metastatic non-small cell lung cancer: younger versus older adults

Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy

Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing

Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach

Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world

Cell Death and Mechanoprotection by Filamin A in Connective Tissues after Challenge by Applied Tensile Forces

Uptake of second-line anticancer therapy after first-line pembrolizumab in patients with stage IV non–small cell lung cancer with PD-L1 > 50%: Comparison between clinical trials and the real world

Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

Overall survival benefits of advances in NSCLC systemic treatments: Younger versus older adults

Molecular testing in non-small cell lung cancer: a snapshot of The Royal Free London NHS Foundation Trust experience

The efficacy of crizotinib in patients with -positive nonsmall cell lung cancer

Intratumoral heterogeneity in programmed death‐ligand 1 immunoreactivity is associated with variation in non‐small cell lung carcinoma histotype

Confirmation of germline variants identified by tumor testing: A population-based study

Lung Cancer in Canada

International Interlaboratory Digital PCR Study Demonstrating High Reproducibility for the Measurement of a Rare Sequence Variant

Olaratumab: a platelet-derived growth factor receptor-[alpha]-blocking antibody for the treatment of soft tissue sarcoma

An audit of the management of Staphylococcus aureus bloodstream infections over two years in a District General Hospital in the United Kingdom

An audit of the management of Staphylococcus aureus bloodstream infections over two years in a District General Hospital in the United Kingdom: Category: Clinical lesson

Olaratumab for the treatment of soft-tissue sarcoma

Optimising Cancer Vaccine Design in Sarcoma

Quantification of circulating free and circulating tumor DNA in pretreated EGFR mutant NSCLC to inform patient outcomes

Understanding lung cancer molecular subtypes

The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer

The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space

Aktive Filter

Suchergebnisse filtern